InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Wapnick Pamela. Officer active across 2 companies, notably Metagenomi, Inc.. Aggregated, 11 disclosures have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €34k. Activity tracked since 1 April 2024. The latest transaction was filed on 8 September 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Pamela Wapnick is an insider linked to Metagenomi, Inc. and Metagenomi Therapeutics, Inc., where she is Chief Financial Officer. She has 10 filings in total, and across the 10 sampled filings between 2024-04-03 and 2026-04-03, the amounts show 0 in buys and 31614 in sells, with Cession as the dominant transaction nature.